ASCCP Cervical Cancer Management Guidelines Support Dual-Stain Triage Testing
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read MorePosted by Andy Lundin | Mar 11, 2024 | Cervical (HPV), Cytology |
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read MorePosted by Chris Wolski | Mar 6, 2024 | Lab Management |
These six best practices, which include automated software options and third-party assistance, can lead to better reimbursement.
Read MorePosted by Chris Wolski | Mar 5, 2024 | Diagnostic Technologies |
While routine testing showed gains, clinical lab volumes for other specialties have either remained flat or have exhibited ebbs and flows.
Read MorePosted by Andy Lundin | Feb 29, 2024 | Cancer |
The Riskguard test detects genetic changes that can increase risk for 10 common cancers, using a simple blood or saliva sample.
Read MorePosted by Andy Lundin | Feb 29, 2024 | Emerging & Zoonotic Diseases |
A study showcased the application of Flongle sequencing as a cost-efficient and rapid method to detect the zoonotic pathogen.
Read More